Search results
Former Nurse Pleads Guilty in Connection to the Diversion of Dangerous Narcotics by Medical Professionals June 3, 2024 Palomar Hospital Pays $250,000 for Diverting Fentanyl
Renew Your Application HERE! EMAIL ADDRESSES ARE REQUIRED. Registrants must have a current and active email address listed on their registration in order to receive important information from the DEA, such as registration renewal notices.
The mission of DEA's Diversion Control Division is to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources while ensuring an adequate and uninterrupted supply for legitimate medical, commercial, and scientific needs.
Modify eligible DEA registration to collect pharmaceutical controlled substances from ultimate users (e.g., patients); Modify DEA registration to stop being a collector; Modify existing collector registration information
Quotas - Final Order: Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024 (PDF)
Having Trouble Logging In? Email Us: DEA.Registration.Help@usdoj.gov. Please includethe name on your Application/Registration and one of the following: DEA Number, Application Control Number, or Web Tracking Number. Telephone Us Toll Free:(800) 882-9539.
DEA is committed to tackling the nationwide drug overdose and poisoning crisis that is driven by criminal drug networks. This work includes a critical focus on outreach, prevention, engagement, and education with law enforcement partners and communities across the nation.
The Diversion Investigator position is a core series position within the DEA. Diversion Investigators enforce the Controlled Substances Act (CSA) and the Chemical Diversion and Trafficking Act (CDTA) regarding the manufacture, distribution and dispensing of legally produced controlled substances and listed chemicals in order to prevent ...
Combating drug diversion is a top priority for the U.S. Drug Enforcement Administration (DEA). The DEA’s Diversion Control Division focuses its efforts entirely on uncovering and investigating cases of drug diversion, and its Diversion Investigators work closely with prosecutors at the U.S. Department of Justice (DOJ) to pursue charges under ...
As the United States’ opioid epidemic continues to garner the attention of the Drug Enforcement Administration (DEA) and other federal agencies, pharmacies are increasingly finding themselves on the front lines of the government’s fight to deter and prevent opioid diversion.
